# Phosphoenolpyruvate Carboxykinase, a Key Enzyme That Controls Blood Glucose, Is a Target of Retinoic Acid Receptor-Related Orphan Receptor α

**Authors:** Hiroshi Matsuoka, Akiho Shima, Daisuke Kuramoto, Daisuke Kikumoto, Takashi Matsui, Akihiro Michihara

PMC · DOI: 10.1371/journal.pone.0137955 · PLoS ONE · 2015-09-18

## TL;DR

This study shows that RORα, a receptor protein, directly controls PEPCK, an enzyme key to blood glucose regulation in the liver.

## Contribution

The paper identifies RORα as a novel regulator of PEPCK transcription through direct binding and synergistic interactions with C/EBP.

## Key findings

- RORα binds the PEPCK promoter in a sequence-specific manner.
- RORα and C/EBP synergistically enhance PEPCK transcription.
- RORα suppression reduces PEPCK transcription and inhibits hepatic gluconeogenesis.

## Abstract

Phosphoenolpyruvate carboxykinase (PEPCK) catalyzes a committed and rate-limiting step in hepatic gluconeogenesis, and its activity is tightly regulated to maintain blood glucose levels within normal limits. PEPCK activity is primarily regulated through hormonal control of gene transcription. Transcription is additionally regulated via a cAMP response unit, which includes a cAMP response element and four binding sites for CCAAT/enhancer-binding protein (C/EBP). Notably, the cAMP response unit also contains a putative response element for retinoic acid receptor-related orphan receptor α (RORα). In this paper, we characterize the effect of the RORα response element on cAMP-induced transcription. Electrophoresis mobility shift assay indicates that RORα binds this response element in a sequence-specific manner. Furthermore, luciferase reporter assays indicate that RORα interacts with C/EBP at the PEPCK promoter to synergistically enhance transcription. We also found that cAMP-induced transcription depends in part on RORα and its response element. In addition, we show that suppression of RORα by siRNA significantly decreased PEPCK transcription. Finally, we found that a RORα antagonist inhibits hepatic gluconeogenesis in an in vitro glucose production assay. Taken together, the data strongly suggest that PEPCK is a direct RORα target. These results define possible new roles for RORα in hepatic gluconeogenesis.

## Linked entities

- **Genes:** PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial) [NCBI Gene 5106]
- **Proteins:** RORA (RAR related orphan receptor A), CEBPA (CCAAT enhancer binding protein alpha)

## Full-text entities

- **Genes:** Rora (RAR-related orphan receptor A) [NCBI Gene 300807], NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], AWAT2 (acyl-CoA wax alcohol acyltransferase 2) [NCBI Gene 158835] {aka ARAT, DC4, DGAT2L4, MFAT, WS}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, NR3C1 (nuclear receptor subfamily 3 group C member 1) [NCBI Gene 2908] {aka GCCR, GCR, GCRST, GR, GRL}, Cyp7b1 (cytochrome P450, family 7, subfamily b, polypeptide 1) [NCBI Gene 13123] {aka D3Ertd552e, hct-1}, Rora (RAR-related orphan receptor alpha) [NCBI Gene 19883] {aka 9530021D13Rik, Nr1f1, ROR1, ROR2, ROR3, nmf267}, CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, Nr1d1 (nuclear receptor subfamily 1, group D, member 1) [NCBI Gene 217166] {aka A530070C09Rik}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Cyp21a1 (cytochrome P450, family 21, subfamily a, polypeptide 1) [NCBI Gene 13079] {aka 21-OH, 21OH, 21OHA, 21OHB, CYP21OH-A, Cyp21}, CYP2C8 (cytochrome P450 family 2 subfamily C member 8) [NCBI Gene 1558] {aka CPC8, CYP2C8DM, CYPIIC8, MP-12/MP-20}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 81646] {aka Creb}, Pck1 (phosphoenolpyruvate carboxykinase 1) [NCBI Gene 362282] {aka GTP, PCK, PEPCK-C, Pepck, RATPEPCK}, G6pc1 (glucose-6-phosphatase catalytic subunit 1) [NCBI Gene 14377] {aka G6Pase, G6pc, G6pt, Glc-6-Pase}, CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050] {aka C/EBP-alpha, CEBP}, RORA (RAR related orphan receptor A) [NCBI Gene 6095] {aka IDDECA, NR1F1, ROR1, ROR2, ROR3, RORa1}, Pck1 (phosphoenolpyruvate carboxykinase 1, cytosolic) [NCBI Gene 18534] {aka PEPCK, PEPCK-C, Pck-1}, Cebpb (CCAAT/enhancer binding protein beta) [NCBI Gene 12608] {aka C/EBPbeta, CRP2, IL-6DBP, LAP, LIP, NF-IL6}, G6pc1 (glucose-6-phosphatase catalytic subunit 1) [NCBI Gene 25634] {aka G6Pase, G6pc, Psme3}, G6PC1 (glucose-6-phosphatase catalytic subunit 1) [NCBI Gene 2538] {aka G6PC, G6PT, G6Pase, GSD1, GSD1a}, GLB1 (galactosidase beta 1) [NCBI Gene 2720] {aka EBP, ELNR1, MPS4B}, BMAL1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 406] {aka ARNTL, ARNTL1, BMAL1c, JAP3, MOP3, PASD3}, MOGAT2 (monoacylglycerol O-acyltransferase 2) [NCBI Gene 80168] {aka DGAT2L5, DGAT2L5., MGAT2, hDC5}, PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial) [NCBI Gene 5106] {aka PEPCK, PEPCK-M, PEPCK2, mtPCK2}, Ncoa2 (nuclear receptor coactivator 2) [NCBI Gene 17978] {aka D1Ertd433e, GRIP-1, Grip1, KAT13C, NCoA-2, SRC-2}, CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 1051] {aka C/EBP-beta, IL6DBP, NF-IL6, TCF5}, Nfkbiz (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta) [NCBI Gene 80859] {aka INAP, Mail}
- **Diseases:** obesity (MESH:D009765), muscular defects (MESH:D009135), osteoporosis (MESH:D010024), hyperglycemia (MESH:D006943), Alzheimer's disease (MESH:D000544), atherosclerosis (MESH:D050197), inflammation (MESH:D007249), cerebellar ataxia (MESH:D002524), vascular dysfunction (MESH:D002561), type 1 diabetes (MESH:D003922), insulinoma (MESH:D007340), diabetes (MESH:D003920), immune abnormalities (MESH:D007154)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Canis lupus familiaris (dog, subspecies) [taxon 9615], Macaca mulatta (rhesus macaque, species) [taxon 9544], Moloney murine leukemia virus (no rank) [taxon 11801], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4575163/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4575163/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC4575163/full.md

---
Source: https://tomesphere.com/paper/PMC4575163